JP2005097320A5 - - Google Patents

Download PDF

Info

Publication number
JP2005097320A5
JP2005097320A5 JP2004362085A JP2004362085A JP2005097320A5 JP 2005097320 A5 JP2005097320 A5 JP 2005097320A5 JP 2004362085 A JP2004362085 A JP 2004362085A JP 2004362085 A JP2004362085 A JP 2004362085A JP 2005097320 A5 JP2005097320 A5 JP 2005097320A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2004362085A
Other versions
JP2005097320A (ja
Filing date
Publication date
Priority claimed from US08/035,443 external-priority patent/US6326353B1/en
Application filed filed Critical
Publication of JP2005097320A publication Critical patent/JP2005097320A/ja
Publication of JP2005097320A5 publication Critical patent/JP2005097320A5/ja
Abandoned legal-status Critical Current

Links

JP2004362085A 1993-03-23 2004-12-14 増強循環エフェクター組成物および方法 Abandoned JP2005097320A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/035,443 US6326353B1 (en) 1993-03-23 1993-03-23 Enhanced circulation effector composition and method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP6521332A Division JPH08508256A (ja) 1993-03-23 1994-03-22 増強循環エフェクター組成物および方法

Publications (2)

Publication Number Publication Date
JP2005097320A JP2005097320A (ja) 2005-04-14
JP2005097320A5 true JP2005097320A5 (ja) 2005-10-27

Family

ID=21882712

Family Applications (2)

Application Number Title Priority Date Filing Date
JP6521332A Pending JPH08508256A (ja) 1993-03-23 1994-03-22 増強循環エフェクター組成物および方法
JP2004362085A Abandoned JP2005097320A (ja) 1993-03-23 2004-12-14 増強循環エフェクター組成物および方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP6521332A Pending JPH08508256A (ja) 1993-03-23 1994-03-22 増強循環エフェクター組成物および方法

Country Status (10)

Country Link
US (1) US6326353B1 (ja)
EP (1) EP0689428B1 (ja)
JP (2) JPH08508256A (ja)
AT (1) ATE175868T1 (ja)
AU (1) AU6368494A (ja)
CA (1) CA2157410C (ja)
DE (1) DE69416116T2 (ja)
DK (1) DK0689428T3 (ja)
ES (1) ES2131190T3 (ja)
WO (1) WO1994021235A1 (ja)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6180134B1 (en) * 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
GB9509016D0 (en) * 1995-05-03 1995-06-21 Royal Free Hosp School Med Tissue entrapment
US5919480A (en) * 1996-06-24 1999-07-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal influenza vaccine composition and method
JP4771563B2 (ja) 1996-12-06 2011-09-14 アムジエン・インコーポレーテツド Ｉｌ−１媒介疾患を処置するためにｉｌ−１インヒビターを使用する組合せ療法
US5827533A (en) * 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US7122636B1 (en) 1997-02-21 2006-10-17 Genentech, Inc. Antibody fragment-polymer conjugates and uses of same
DE69821338T2 (de) 1997-02-21 2004-10-21 Genentech Inc Antikörperfragment-polymerkonjugate
US6013253A (en) * 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
US6468532B1 (en) 1998-01-22 2002-10-22 Genentech, Inc. Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates
US7005504B2 (en) 1998-01-22 2006-02-28 Genentech, Inc. Antibody fragment-peg conjugates
US6458355B1 (en) 1998-01-22 2002-10-01 Genentech, Inc. Methods of treating inflammatory disease with anti-IL-8 antibody fragment-polymer conjugates
AU747391B2 (en) 1998-04-27 2002-05-16 Cantab Biopharmaceuticals Patents Limited Pharmaceutical composition comprising factor VIII and neutral liposomes
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
US7829074B2 (en) 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
WO2002076428A1 (en) * 2001-03-26 2002-10-03 Alza Corporation Liposome composition for improved intracellular delivery of a therapeutic agent
MXPA04000134A (es) 2001-06-26 2005-06-06 Abgenix Inc Anticuerpos para ligandos de osteoprotegerina.
CN1649625A (zh) * 2002-03-01 2005-08-03 图兰恩教育基金管理人 治疗剂或细胞毒性剂与生物活性肽的偶联物
BRPI0314038B8 (pt) 2002-09-06 2021-05-25 Amgen Inc anticorpo humano isolado, molécula de ácido nucleico isolada, vetor, uso de um anticorpo, e, composição farmacêutica
US20040062748A1 (en) * 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
CA2510780A1 (en) * 2002-12-19 2004-07-08 Alza Corporation Method of treating angiogenic tissue growth
US7432331B2 (en) 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
EP1578842B1 (en) 2002-12-31 2009-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
KR20060015534A (ko) 2003-04-25 2006-02-17 더 펜 스테이트 리서치 파운데이션 성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
EP1653996A2 (en) * 2003-08-08 2006-05-10 Novo Nordisk Health Care AG Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
ATE401057T1 (de) * 2004-10-08 2008-08-15 Alza Corp Verfahren zur einführung eines lipid-verknüpften teils in eine vorgeformte lipidanordnung mit mikrowellen
TW200618820A (en) * 2004-11-05 2006-06-16 Alza Corp Liposome formulations of boronic acid compounds
TW200726485A (en) * 2005-07-01 2007-07-16 Alza Corp Liposomal delivery vehicle for hydrophobic drugs
US20070055200A1 (en) 2005-08-10 2007-03-08 Gilbert Scott J Needle-free jet injection drug delivery device
US20070134312A1 (en) * 2005-09-12 2007-06-14 Hussein Mohamad A Liposomes for treatment of multiple myeloma
AR056806A1 (es) 2005-11-14 2007-10-24 Amgen Inc Moleculas quimericas de anticuerpo rankl- pth/ pthrp
US20070264322A1 (en) * 2006-05-10 2007-11-15 Huang Ken S Method for making liposomes conjugated with temperature-sensitive ligands
US7833527B2 (en) 2006-10-02 2010-11-16 Amgen Inc. Methods of treating psoriasis using IL-17 Receptor A antibodies
US8323635B2 (en) 2007-11-14 2012-12-04 General Regeneratives, Ltd. Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
MX2011006456A (es) 2008-12-22 2011-10-11 Creabilis S A Sintesis de conjugados de polimero de compuestos de indolocarbazola.
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
CN101690801B (zh) 2009-10-26 2012-08-01 上海交通大学 白细胞介素-1受体拮抗剂的用途及其药物组合物
TWI397428B (zh) * 2009-12-29 2013-06-01 Ind Tech Res Inst 標的第四介白素受體之傳輸系統
DE102010043733A1 (de) 2010-11-10 2012-05-10 Oxprotect Gmbh Unbeladene PEGylierte Liposomen zur Verwendung als Arzneimittel zur Prophylaxe und Therapie von hämorrhagischen und thrombo- embolischen Erkrankungen
US20140234330A1 (en) 2011-07-22 2014-08-21 Amgen Inc. Il-17 receptor a is required for il-17c biology
EP2679236A1 (de) * 2012-06-29 2014-01-01 Zentrum für biomedizinische Technologie der Donau- Universität Krems Dosierungsanleitung für endotoxinbindende Lipopeptide
WO2014050509A1 (ja) * 2012-09-25 2014-04-03 テルモ株式会社 リポソームおよびリポソーム製剤
SG11201508433TA (en) 2013-04-12 2015-11-27 Andaloussi Samir El Therapeutic delivery vesicles
US20160000936A1 (en) 2014-06-10 2016-01-07 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
GB201417589D0 (en) 2014-10-06 2014-11-19 Cantab Biopharmaceuticals Patents Ltd Pharmaceutical Formulations
US10041044B2 (en) 2016-07-29 2018-08-07 Trustees Of Boston University Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
EP3836954A1 (en) 2018-08-13 2021-06-23 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
CN111217993B (zh) * 2018-11-26 2022-05-20 沈阳药科大学 一种聚乙二醇化酚红及其制备方法和用途
WO2023222565A1 (en) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4948590A (en) * 1987-06-09 1990-08-14 Yale University Avidin or streptavidin conjugated liposomes
AU5858690A (en) * 1989-06-14 1991-01-08 Cetus Corporation Polymer/antibiotic conjugate
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
JPH05506251A (ja) * 1991-02-14 1993-09-16 バクスター、インターナショナル、インコーポレイテッド リポソームへの成長ホルモン類の結合
JP3220180B2 (ja) * 1991-05-23 2001-10-22 三菱化学株式会社 薬剤含有タンパク質結合リポソーム

Similar Documents

Publication Publication Date Title
BE2024C508I2 (ja)
BE2022C549I2 (ja)
BE2020C513I2 (ja)
BE2020C517I2 (ja)
BE2019C540I2 (ja)
BE2018C045I2 (ja)
BE2017C027I2 (ja)
BE2017C023I2 (ja)
BE2017C002I2 (ja)
BE2016C067I2 (ja)
BRPI0518216C1 (ja)
BRPI0515516B8 (ja)
BR122015024347A2 (ja)
BRPI0508002A (ja)
JP2005097320A5 (ja)
JP2005337301A5 (ja)
BE2016C042I2 (ja)
JP2006041304A5 (ja)
JP2005322336A5 (ja)
JP2005338220A5 (ja)
IN2006KO02923A (ja)
BR122018073034B8 (ja)
BRPI0508029A (ja)
BRPI0419105B8 (ja)
JP2006013798A5 (ja)